Cargando…
On Treatments and Tests Deferred: Preparing for Collateral Damage from COVID-19
Autores principales: | Jain, Snigdha, Santhosh, Lekshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640720/ https://www.ncbi.nlm.nih.gov/pubmed/32667208 http://dx.doi.org/10.1513/AnnalsATS.202004-387VP |
Ejemplares similares
-
Collateral damage and CRISPR genome editing
por: Thomas, Mark, et al.
Publicado: (2019) -
The collateral damage of the COVID-19 pandemic on surgical health care in sub-Saharan Africa
por: Chu, Kathryn, et al.
Publicado: (2020) -
How to cope with emerging viral diseases: lessons from South Korea's strategy for COVID-19, and collateral damage to cardiometabolic health
por: Lim, Soo, et al.
Publicado: (2022) -
Preparing for COVID-19–related Drug Shortages
por: Shuman, Andrew G., et al.
Publicado: (2020) -
How prepared is Brazil to tackle the COVID-19 disease?
por: Moreira, Rodrigo Martins, et al.
Publicado: (2020)